DUBLIN -- (BUSINESS WIRE) -- Research and Markets (http://www.researchandmarkets.com/research/98112b/radiopharmaceutica) has announced the addition of the "Radiopharmaceuticals - Global Strategic Business Report" report to their offering.
This report analyzes the US and the European markets for Radiopharmaceuticals in US$ Million by the following Product Segments: Diagnostic Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets.
The Report Profiles 65 Companies Including Many Key and Niche Players Such As:
Actinium Pharmaceuticals, Inc., Advanced Medical Isotope Corporation, Alseres Pharmaceuticals, Inc., Bayer HealthCare Pharmaceuticals, Bio-Nucleonics, Inc., Bracco Diagnostics, Inc., Cardinal Health, Inc., Cellectar, LLC., Cell Therapeutics, Inc., Covidien Imaging Solutions, EUSA Pharma (Europe) Ltd., Jubilant DraxImage Inc., GE Healthcare Limited, GlaxoSmithKline Plc, IBA Group, Immunomedics, Inc., Lantheus Medical Imaging, Inc, Nordion, Molecular Insight Pharmaceuticals, Inc., Novelos Therapeutics Inc., Peregrine Pharmaceuticals, Inc., PETNET Pharmaceuticals, Inc., Pharmalucence, Inc., Spectrum Pharmaceuticals, Inc., and Triad Isotopes, Inc.
Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Key Topics Covered:
1. Introduction, Methodology & Product Definitions
2. Industry Overview
3. Product Overview
4. Product Innovations/Introductions
5. Recent Industry Activity
6. Focus on Select Players
7. Global Market Perspective
8. the United States
9. Canada
10. Japan
11. Europe
12. Asia-Pacific
13. Rest of World
For more information visit http://www.researchandmarkets.com/research/98112b/radiopharmaceutica
Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716